An estimated 98% of restaurants in New York City are no longer using artificial trans fat in oils, shortening, and spreads, reports the New York City Department of Healthin a perspective on the implementation and short-term results of the city’s ban on trans-fatty acids. Comparatively, surveys performed before the ban …

Reducing levels of a brain enzyme may curb appetite and boost energy, thereby helping people to control their weight, and reduce the risk of developing Type 2 diabetes, says a new study.

A New Zealand biotech company began a trial last week that implanted cells from newborn pigs into eight human volunteers as an experimental treatment for their diabetes and the participants will not use immunosuppressant drugs.

The mothers health prior to conception is more important then previously thought. Maternal nutrition, protein intake and level of fat in the diet may cause epigenetic changes in the developing fetus that can have long-term health consequences.

Compared with patients with moderately controlled glucose levels, diabetic patients who have heart failure and either too high or too low glucose levels may be at increased risk of death, said researchers in a report.

People who adhere to a prudent diet, exercise regularly, and maintain a normal weight can significantly lower their lifetime risk of developing heart failure or hypertension, according to two new studies.

A low-carbohydrate diet may have effects similar to those of a low-fat diet on weight and hemoglobin A1c levels in patients with Type 2 diabetes, but patients following the low-carbohydrate diet have a greater increase in high-density lipoprotein (HDL) cholesterol levels after 1 year, according to the results of a …

High density lipoprotein (HDL) cholesterol levels are associated with the risk of ischemic heart disease and cerebrovascular disease in elderly diabetics, according to recent published findings.

Prevalence of obesity in black Americans is 50% higher than that of white Americans, with obesity rates in Hispanics falling roughly halfway between the two groups, according to new statistics released.

Novo Nordisk data presented last week, showed that when taken by itself, once-daily liraglutide, an investigational treatment for Type 2 diabetes, leads to statistically significant and sustained reductions in blood sugar and weight in African Americans with Type 2 diabetes, as compared to glimepiride.